Latest DEF 14A proxy statements
NYSE
Keysight Technologies announces its 2026 Annual Meeting agenda, highlighting strong FY25 financial results and proposals for board declassification and director elections.
NASDAQ
Fluence Energy, Inc. announces its 2026 Annual Meeting agenda, revealing lower-than-anticipated FY2025 revenue and executive compensation shortfalls despite strategic advancements and record backlog.
NASDAQ
Enanta Pharmaceuticals, Inc. announced the agenda for its Annual Meeting of Stockholders on March 11, 2026, including director elections and equity plan amendments.
NASDAQ
SNEX
Stonex Group INCStoneX Group Inc. announced its annual stockholders' meeting to be held on March 10, 2026, outlining proposals for director elections, auditor ratification, and an advisory vote on executive compensation, alongside reporting strong fiscal year 2025 financial performance and strategic acquisitions.
NASDAQ
Ark Restaurants Corp. announced its 2026 Annual Meeting of Shareholders to elect six directors and ratify its independent auditor, alongside a reduction in board size following a director's passing.
AMEX
Gold Resource Corporation has entered into an Arrangement Agreement and Plan of Merger with Goldgroup Mining Inc., where Gold Resource will become a wholly-owned subsidiary of Goldgroup.
NASDAQ
Enanta Pharmaceuticals, Inc. will hold its 2026 Annual Meeting to elect directors, approve a 1.6 million share increase for its equity incentive plan, and ratify executive compensation and auditor appointment.
NASDAQ
Aptevo Therapeutics Inc. calls a special meeting to approve an amendment to its Certificate of Incorporation and a potential $60 million equity issuance under a Standby Equity Purchase Agreement.
NASDAQ
KALA
Kala Bio, INCKala Bio, Inc. filed a supplement to its 2025 Annual Meeting proxy statement, updating the biography of Class II Director Nominee David Lazar to reflect his recent and current executive and board roles across multiple public companies.
OQX
Parks! America, Inc. announced its Annual Meeting of Stockholders for March 20, 2026, to vote on director elections, auditor ratification, and executive compensation.
NASDAQ
Arrowhead Pharmaceuticals, Inc. announced its 2026 Annual Meeting of Stockholders to be held virtually on March 19, 2026, to vote on director elections, executive compensation, an incentive plan, and auditor ratification.
NASDAQ
Arrowhead Pharmaceuticals, Inc. announces its 2026 Annual Meeting of Stockholders, highlighting significant financial improvements, key regulatory approvals, and pipeline advancements.
Forward Industries, Inc. seeks shareholder approval for a strategic reincorporation to Texas, an expanded equity incentive plan, and director elections at its upcoming 2026 Annual Meeting.
OQB
Destiny Media Technologies Inc. filed its definitive proxy statement for the 2026 Annual General Meeting, outlining proposals for director elections and auditor ratification.
NASDAQ
Amicus Therapeutics provides preliminary unaudited financial results for 2025, showing robust product revenue growth ahead of its acquisition by BioMarin.
Quipt Home Medical Corp. announced the expiration of the HSR waiting period for its acquisition by 1567208 B.C. Ltd. for $3.65 per share in cash, moving the transaction closer to completion.
NASDAQ
Xilio Therapeutics, Inc. will hold a special meeting on February 23, 2026, for stockholders to vote on a reverse stock split to meet Nasdaq's minimum bid price requirement.
NYSE
Orion Properties Inc. announced a strategic options review process to maximize stockholder value and a cooperation agreement with The Kawa Fund Limited.
AMEX
Gold Resource Corporation announced a definitive agreement to merge with Goldgroup Mining Inc., offering GRC stockholders a 39% premium and approximately 40% ownership in the combined company.
NASDAQ
BLBD
Blue Bird CORPBlue Bird Corporation has filed definitive additional proxy soliciting materials with the SEC.
NASDAQ
BLBD
Blue Bird CORPBlue Bird Corporation announces its 2026 Annual Meeting of Stockholders to vote on director elections, an expanded equity incentive plan, officer liability limitation, and executive compensation.
NYSE
Compass Minerals International, Inc. announced its 2026 Annual Meeting of Stockholders to be held on March 5, 2026, outlining key proposals including director elections, executive compensation, and auditor ratification.
NASDAQ
SANM
Sanmina CORPSanmina Corporation has filed definitive additional proxy soliciting materials with the SEC.
NYSE
Eagle Point Credit Company Inc. issues a reminder to shareholders to cast their votes for the upcoming Special Meeting.
NYSE
Clearwater Analytics Holdings, Inc.'s go-shop period for its proposed merger with GT Silver BidCo, Inc. expired without any alternative acquisition proposals.
Klotho Neurosciences, Inc. will hold a Special Meeting to vote on a reverse stock split to meet Nasdaq listing requirements and an increase in its equity incentive plan to attract and retain talent.
Sealed Air Corporation's Board unanimously recommends stockholders approve the $42.15 per share all-cash acquisition by Sword Purchaser, LLC, an affiliate of Clayton, Dubilier & Rice, LLC.
NYSE
Compass Minerals International, Inc. announces its 2026 annual meeting of stockholders to elect directors, approve executive compensation, and ratify auditors, alongside reporting fiscal 2025 financial highlights.
NASDAQ
SANM
Sanmina CORPSanmina Corporation announced robust fiscal 2025 financial results, including 7.4% revenue growth and expanded operating margins, alongside the strategic acquisition of ZT Systems to bolster its Cloud and AI infrastructure offerings.
NASDAQ
Advanced Biomed Inc. announces a planned reverse stock split, ranging from 1:2 to 1:100, to maintain its listing on The Nasdaq Capital Market.